DEVELOPMENT OF A VAV2 ANTISENSE OLIGONUCLEOTIDE THERAPEUTIC FOR ALS

$2,490,000FY2025Defense Health AgencyDOD

University Of Southern California, Los Angeles CA

Investigators

View source on USAspending →